Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

Open access
Johannet, Paul, Coudray, Nicolas, Donnelly, Douglas M., Jour, George, Illa-Bochaca, Irineu, Xia, Yuhe, Johnson, Douglas B., Wheless, Lee, Patrinely, James R., Nomikou, Sofia, Rimm, David L., Pavlick, Anna C., Weber, Jeffrey S., Zhong, Judy, Tsirigos, Aristotelis, Osman, Iman·2021·Clinical Cancer Research

Abstract

Purpose: Several biomarkers of response to immune checkpoint inhibitors (ICI) show potential but are not yet scalable to the clinic. We developed a pipeline that integrates deep learning on histology specimens with clinical data to predict ICI response in advanced melanoma. Experimental Design: We used a training cohort from New York University (New York, NY) and a validation cohort from Vanderbilt University (Nashville, TN). We built a multivariable classifier that integrates neural network predictions with clinical data. A ROC curve was generated and the optimal threshold was used to stratify patients as high versus low risk for progression. Kaplan–Meier curves compared progression-free survival (PFS) between the groups. The classifier was validated on two slide scanners (Aperio AT2 and Leica SCN400). Results: The multivariable classifier predicted response with AUC 0.800 on images from the Aperio AT2 and AUC 0.805 on images from the Leica SCN400. The classifier accurately stratified patients into high versus low risk for disease progression. Vanderbilt patients classified as high risk for progression had significantly worse PFS than those classified as low risk (P = 0.02 for the Aperio AT2; P = 0.03 for the Leica SCN400). Conclusions: Histology slides and patients' clinicodemographic characteristics are readily available through standard of care and have the potential to predict ICI treatment outcomes. With prospective validation, we believe our approach has potential for integration into clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-20-2415

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 180

Metadata

Authors
Johannet, P., Coudray, N., Donnelly, D. M., Jour, G., Illa-Bochaca, I., Xia, Y., Johnson, D. B., Wheless, L., Patrinely, J. R., Nomikou, S., Rimm, D. L., Pavlick, A. C., Weber, J. S., Zhong, J., Tsirigos, A., & Osman, I.
Venue
Clinical Cancer Research
Published
2021-01-01
Volume
27
Issue
1
Pages
131-140
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W3103134014
Cited by
180
References
9
FWCI
6.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-20-2415
The paper
Johannet, P., Coudray, N., Donnelly, D. M., Jour, G., Illa-Bochaca, I., Xia, Y., Johnson, D. B., Wheless, L., Patrinely, J. R., Nomikou, S., Rimm, D. L., Pavlick, A. C., Weber, J. S., Zhong, J., Tsirigos, A., & Osman, I. (2021). Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-20-2415

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.